BioCentury
ARTICLE | Financial News

Endo planning $700M note deal

May 27, 2011 12:32 AM UTC

Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP) plans to sell $700 million in senior unsecured notes. The biotech plans to use a portion of the proceeds to fund its previously announced acquisition o...